515 related articles for article (PubMed ID: 19505389)
1. Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients.
Quaglino P; Comessatti A; Ponti R; Peroni A; Mola F; Fierro MT; Savoia P; Novelli M; Bernengo MG
Int J Immunopathol Pharmacol; 2009; 22(2):353-62. PubMed ID: 19505389
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory T cells.
Rao V; Saunes M; Jørstad S; Moen T
Clin Immunol; 2009 Dec; 133(3):303-13. PubMed ID: 19773201
[TBL] [Abstract][Full Text] [Related]
3. CD4+CD25+ lymphocyte subsets in chronic graft versus host disease patients undergoing extracorporeal photochemotherapy.
Rubegni P; Sbano P; Cevenini G; Perari MG; Marotta G; Risulo M; Carcagnì MR; D' Ascenzo G; De Aloe G; Fimiani M
Int J Immunopathol Pharmacol; 2007; 20(4):801-7. PubMed ID: 18179753
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
[TBL] [Abstract][Full Text] [Related]
5. The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.
Shiue LH; Couturier J; Lewis DE; Wei C; Ni X; Duvic M
Photodermatol Photoimmunol Photomed; 2015 Jul; 31(4):184-94. PubMed ID: 25772268
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
Bladon J; Taylor P
Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
[TBL] [Abstract][Full Text] [Related]
7. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T Cells in Chronic Graft-Versus-Host Disease After Extracorporeal Photopheresis: Correlation With Skin and Global Organ Responses, and Ability to Taper Steroids.
Denney HA; Whittle RJ; Lai J; Jacques RM; Taylor PC
Transplantation; 2017 Jan; 101(1):204-211. PubMed ID: 27007227
[TBL] [Abstract][Full Text] [Related]
9. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production.
Schmitt S; Johnson TS; Karakhanova S; Näher H; Mahnke K; Enk AH
Transplantation; 2009 Aug; 88(3):411-6. PubMed ID: 19667946
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.
Fimiani M; Di Renzo M; Rubegni P
Br J Dermatol; 2004 Jun; 150(6):1055-60. PubMed ID: 15214889
[TBL] [Abstract][Full Text] [Related]
12. Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis.
George JF; Gooden CW; Guo L; Kirklin JK
J Heart Lung Transplant; 2008 Jun; 27(6):616-22. PubMed ID: 18503960
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral CD4+ T lymphocytes.
Zouboulis CC; Schmuth M; Doepfmer S; Dippel E; Orfanos CE
Dermatology; 1998; 196(3):305-8. PubMed ID: 9621137
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal photochemotherapy (ECP) in treatment of patients with c-GVHD and CTCL.
Gasová Z; Spísek R; Dolezalová L; Marinov I; Vítek A
Transfus Apher Sci; 2007 Apr; 36(2):149-58. PubMed ID: 17376742
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo.
Bladon J; Taylor P
J Clin Apher; 2002; 17(4):177-82. PubMed ID: 12494410
[TBL] [Abstract][Full Text] [Related]
16. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.
Darvay A; Salooja N; Russell-Jones R
J Eur Acad Dermatol Venereol; 2004 May; 18(3):279-84. PubMed ID: 15096136
[TBL] [Abstract][Full Text] [Related]
17. [The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection].
Liu YJ; Wu DP; Li CX; He J; Qiu QC; Zhang XG
Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):835-8. PubMed ID: 17217750
[TBL] [Abstract][Full Text] [Related]
18. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.
Alfred A; Taylor PC; Dignan F; El-Ghariani K; Griffin J; Gennery AR; Bonney D; Das-Gupta E; Lawson S; Malladi RK; Douglas KW; Maher T; Guest J; Hartlett L; Fisher AJ; Child F; Scarisbrick JJ
Br J Haematol; 2017 Apr; 177(2):287-310. PubMed ID: 28220931
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal photochemotherapy.
Maeda A
J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
[TBL] [Abstract][Full Text] [Related]
20. Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD).
Rutella S; Valentini CG; Ceccarelli S; Romano MT; Brescia LP; Milano GM; Locatelli F
Transfus Apher Sci; 2014 Jun; 50(3):340-8. PubMed ID: 24780391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]